We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Columvi
Australian Public Assessment Report
Device/Product Name
Columvi
Active ingredients
Glofitamab
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-01989-1-6
Submission Type
New biological medicine
Decision
Approved